149 related articles for article (PubMed ID: 26233268)
1. Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: Utility of dynamic, contrast enhancement and single-shot T2-weighted sequences.
Becker-Weidman D; Kalb B; Mittal PK; Harri PA; Arif-Tiwari H; Farris AB; Chen Z; Sungjin K; Martin DR
Eur J Radiol; 2015 Nov; 84(11):2045-51. PubMed ID: 26233268
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
4. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
5. [The differentiation of adrenal gland tumors: an improvement in accuracy by a combination of fat-sensitive, T2-weighted and contrast-enhanced MR sequences].
Zimmermann GG; Debatin JF; Krestin GP
Rofo; 1997 Aug; 167(2):153-9. PubMed ID: 9333356
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the adrenal gland.
Boland GW; Lee MJ
Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
[TBL] [Abstract][Full Text] [Related]
7. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging.
Chung JJ; Semelka RC; Martin DR
J Magn Reson Imaging; 2001 Feb; 13(2):242-8. PubMed ID: 11169830
[TBL] [Abstract][Full Text] [Related]
8. Diffusion tensor imaging in the differentiation of adrenal adenomas and metastases.
Işık Y; Gürses B; Taşdelen N; Kılıçkesmez O; Fırat Z; Ordu C; Gürmen N
Diagn Interv Radiol; 2012; 18(2):189-94. PubMed ID: 21960162
[TBL] [Abstract][Full Text] [Related]
9. Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: can biopsy be obviated?
Slapa RZ; Jakubowski W; Januszewicz A; Kasperlik-Zaluska AA; Dabrowska E; Fijuth J; Feltynowski T; Tarnawski R; Królicki L
Eur Radiol; 2000; 10(1):95-104. PubMed ID: 10663723
[TBL] [Abstract][Full Text] [Related]
10. Delayed enhanced CT of lipid-poor adrenal adenomas.
Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
[TBL] [Abstract][Full Text] [Related]
11. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies.
Słapa RZ; Jakubowski W; Dabrowska E; Januszewicz A; Tymińska B; Feltynowski T; Lapiński M; Fijuth J
MAGMA; 1996; 4(3-4):163-79. PubMed ID: 9220405
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT.
Krestin GP; Freidmann G; Fishbach R; Neufang KF; Allolio B
J Comput Assist Tomogr; 1991; 15(1):104-10. PubMed ID: 1987177
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
18. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.
Tsushima Y; Ishizaka H; Matsumoto M
Radiology; 1993 Mar; 186(3):705-9. PubMed ID: 8430178
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
20. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images.
Ichikawa T; Ohtomo K; Uchiyama G; Koizumi K; Monzawa S; Oba H; Nogata Y; Kachi K; Toyama K; Yamaguchi M
Radiology; 1994 Oct; 193(1):247-50. PubMed ID: 8090900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
